[1] |
Forman BM, Tontonoz P, Chen J, et al. 15-Deoxy-delta12, 14 -prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma[J].Cell, 1995, 83(5): 803-12.
|
[2] |
Tennis MA, Van Scoyk MM, Freeman SV,et al. Sprouty-4 inhibits transformed cell growth, migration and invasion, and epithelialmesenchymal transition, and is regulated by Wnt7A through PPARgamma in non-small cell lung cancer[J].Mol Cancer Res,2010, 8(6):833-43.
|
[3] |
Papi A, Rocchi P, Ferreri AM, et al. RXRgamma and PPARgamma ligands in combination to inhibit proliferation and invasiveness in colon cancer cell[J].Cancer Lett,2010, 297(1):65-74.
|
[4] |
Simpson-Haidaris PJ, Pollock SJ, Ramon S, et al. Anticancer role of PPARgamma agonists in hematological malignancies found in the vasculature, marrow and eyes[J].PPAR Res,2010, 20 10:814609.
|
[5] |
Shim J, Kim BH, Kim YI, et al. The peroxisome proliferatoractivated receptor gamma ligands, pioglitazone and 15-deoxy- Delta(12,14)-prostaglandin J(2), have antineoplastic effects against hepatitis B virus-associated hepatocellular carcinoma cells[J].Int J Oncol,2010, 36(1):223-31.
|
[6] |
Toaldo C, Pizzimenti S, Cerbone A, et al. PPARgamma ligands inhibit telomerase activity and hTERT expression through modulation of the Myc/Mad/Max network in colon cancer cells[J]. J Cell Mol Med,2010, 14(6A):1347-57.
|
[7] |
Diers AR, Dranka BP, Ricart KC, et al. Modulation of mammary cancer cell migration by 15-deoxy-Delta(12,14)-prostaglandin J(2) : implications for anti-metastatic therapy[J].Biochem J,2010, 43 0(1):69-78.
|
[8] |
Ma XM, Yu H, Huai N. Peroxisome proliferator-activated receptorgamma is essential in the pathogenesis of gastric carcinoma[J]. World J Gastroenterol,2009,15(31):3874-83.
|
[9] |
Wakamatsu Y, Sakamoto N, Oo HZ,et al. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer[J]. Pathol Int, 2012, 62 (2):112-9.
|
[10] |
Shin SW, Seo CY, Han H, et al.15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity[J].Clin Cancer Res,2009,15(17):5414-25.
|
[11] |
Zhang ZH, Chen Y, Zhao HJ, et al. Silencing of heparanase by siRNA inhibits tumor metastasis and angiogenesis of human breast cancer in vitro and in vivo[J]. Cancer Biol Ther, 2007, 6( 4):587-95.
|
[12] |
Gao H, Wang JY, Shen XZ, et al. Preparation of magnetic polybutylcyanoacrylate nanospheres encapsulated with aclacinomycin A and its effect on gastric tumor[J]. World J Gastroenterol, 2004 ,10(14):2010-3.
|
[13] |
Rivette AS, Tokar EJ, Williams DE, et al. Selection of cell lines with enhanced invasive phenotype from xenografts of the human prostate cancer cell line WPE1-NB26[J]. J Exp Ther Oncol, 2005, 5( 2): 111-23.
|